We are live on ! Find out more
TLOG

TetraLogic Pharmaceuticals Corporation
TLOG

Delisted

TLOG was delisted on the 3rd of November, 2016.

Back to rankings

23 hedge funds and large institutions have $81.2M invested in TetraLogic Pharmaceuticals Corporation in 2013 Q4 according to their latest regulatory filings, with 23 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
+23
Holders Change %
–
% of All Funds
0.67%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
23
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OC
Oppenheimer & Co
New York
+$8.36M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$3.34M
3
KCM
Kingdon Capital Management
New York
+$3.24M
4
PRCM
Pine River Capital Management
Minnesota
+$2.73M
5
DCM
Driehaus Capital Management
Illinois
+$2.42M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CV
1
Clarus Ventures
Massachusetts
$44.2M +$36.2M +4,644,705 New
OC
2
Oppenheimer & Co
New York
$10.2M +$8.36M +1,072,115 New
Wellington Management Group
3
Wellington Management Group
Massachusetts
$4.08M +$3.34M +428,300 New
KCM
4
Kingdon Capital Management
New York
$3.95M +$3.24M +415,000 New
PRCM
5
Pine River Capital Management
Minnesota
$3.33M +$2.73M +350,000 New
DCM
6
Driehaus Capital Management
Illinois
$2.95M +$2.42M +310,301 New
PC
7
PointState Capital
New York
$2.29M +$1.87M +240,000 New
NIP
8
Nicholas Investment Partners
California
$1.92M +$1.57M +201,193 New
EA
9
Emerald Advisers
Pennsylvania
$1.67M +$1.37M +175,000 New
SFM
10
Sphera Funds Management
Israel
$1.67M +$1.37M +175,000 New
Alyeska Investment Group
11
Alyeska Investment Group
Illinois
$1.21M +$995K +127,500 New
FWC
12
First Washington Corp
Washington
$1.08M +$882K +113,000 New
Goldman Sachs
13
Goldman Sachs
New York
$522K +$428K +54,865 New
Deutsche Bank
14
Deutsche Bank
Germany
$499K +$410K +52,500 New
Bank of New York Mellon
15
Bank of New York Mellon
New York
$465K +$381K +48,807 New
CCA
16
Catalyst Capital Advisors
New York
$354K +$290K +37,180 New
California Public Employees Retirement System
17
California Public Employees Retirement System
California
$331K +$314K +40,257 New
Morgan Stanley
18
Morgan Stanley
New York
$182K +$149K +19,086 New
MAA
19
Managed Account Advisors
New Jersey
$137K +$112K +14,398 New
VKH
20
Virtu KCG Holdings
New York
$105K +$86.4K +11,078 New
TRCT
21
Tower Research Capital (TRC)
New York
$31K +$25.6K +3,286 New
U
22
UBS
Switzerland
$18K +$14.8K +1,902 New
Citigroup
23
Citigroup
New York
$12K +$9.57K +1,226 New

TLOG Hedge Fund Activity: Q4 2013 in Review

23 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in TetraLogic Pharmaceuticals Corporation (TLOG) for Q4 2013, worth a combined $81.2M.

Buyers outnumbered sellers: 23 funds opened new TLOG positions and 0 closed out — a net gain of 23 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Oppenheimer & Co, opening a new position worth an estimated $8.36M.

  • 23 institutional investors held TetraLogic Pharmaceuticals Corporation (TLOG) as of Q4 2013, up from 0 in Q3 2013.
  • Funds reported $81.2M of TetraLogic Pharmaceuticals Corporation stock for Q4 2013.
  • 23 funds opened new TetraLogic Pharmaceuticals Corporation positions in Q4 2013 and 0 closed out, a net change of +23 holders.
  • The largest TetraLogic Pharmaceuticals Corporation buyer in Q4 2013 was Oppenheimer & Co, an estimated $8.36M added.

Based on aggregated 13F filings for Q4 2013.